BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30275209)

  • 1. Cholangiocarcinoma: CT-guided High-Dose Rate Brachytherapy (CT-HDRBT) for Limited (<4 cm) and Large (>4 cm) Tumors.
    Jonczyk M; Collettini F; Schnapauff D; Geisel D; Böning G; Feldhaus F; Denecke T; Wieners G; Hamm B; Gebauer B
    Anticancer Res; 2018 Oct; 38(10):5843-5852. PubMed ID: 30275209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).
    Collettini F; Lutter A; Schnapauff D; Hildebrandt B; Puhl G; Denecke T; Wust P; Gebauer B
    Rofo; 2014 Jun; 186(6):606-12. PubMed ID: 24407711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary and metastatic malignancies of the lung: Retrospective analysis of the CT-guided high-dose rate brachytherapy (CT-HDRBT) ablation in tumours <4 cm and ≥4 cm.
    Jonczyk M; Collettini F; Schnapauff D; Geisel D; Böning G; Feldhaus F; Wieners G; Hamm B; Gebauer B
    Eur J Radiol; 2018 Nov; 108():230-235. PubMed ID: 30396661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT-guided high-dose-rate brachytherapy of unresectable hepatocellular carcinoma.
    Collettini F; Schreiber N; Schnapauff D; Denecke T; Wust P; Schott E; Hamm B; Gebauer B
    Strahlenther Onkol; 2015 May; 191(5):405-12. PubMed ID: 25404063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed tomography-guided interstitial HDR brachytherapy (CT-HDRBT) of the liver in patients with irresectable intrahepatic cholangiocarcinoma.
    Schnapauff D; Denecke T; Grieser C; Collettini F; Seehofer D; Sinn M; Banzer J; Lopez-Hänninen E; Hamm B; Wust P; Gebauer B
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):581-7. PubMed ID: 21833806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Percutaneous CT-guided high-dose brachytherapy (CT-HDRBT) ablation of primary and metastatic lung tumors in nonsurgical candidates].
    Collettini F; Schnapauff D; Poellinger A; Denecke T; Banzer J; Golenia MJ; Wust P; Gebauer B
    Rofo; 2012 Apr; 184(4):316-23. PubMed ID: 22297915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of metastases adjacent to the liver hilum.
    Collettini F; Singh A; Schnapauff D; Powerski MJ; Denecke T; Wust P; Hamm B; Gebauer B
    Eur J Radiol; 2013 Oct; 82(10):e509-14. PubMed ID: 23791521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary experience with CT-guided high-dose rate brachytherapy as an alternative treatment for hepatic recurrence of cholangiocarcinoma.
    Kamphues C; Seehofer D; Collettini F; Bahra M; Neuhaus P; Wust P; Denecke T; Gebauer B; Schnapauff D
    HPB (Oxford); 2012 Dec; 14(12):791-7. PubMed ID: 23134179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5-7 cm) and very large (>7 cm) tumours.
    Collettini F; Schnapauff D; Poellinger A; Denecke T; Schott E; Berg T; Wust P; Hamm B; Gebauer B
    Eur Radiol; 2012 May; 22(5):1101-9. PubMed ID: 22173693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT-guided high-dose-rate brachytherapy in the interdisciplinary treatment of patients with liver metastases of pancreatic cancer.
    Wieners G; Schippers AC; Collettini F; Schnapauff D; Hamm B; Wust P; Riess H; Gebauer B
    Hepatobiliary Pancreat Dis Int; 2015 Oct; 14(5):530-8. PubMed ID: 26459730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation.
    Ricke J; Wust P; Wieners G; Beck A; Cho CH; Seidensticker M; Pech M; Werk M; Rosner C; Hänninen EL; Freund T; Felix R
    J Vasc Interv Radiol; 2004 Nov; 15(11):1279-86. PubMed ID: 15525748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CT-Guided brachytherapy. A novel percutaneous technique for interstitial ablation of liver metastases].
    Ricke J; Wust P; Stohlmann A; Beck A; Cho CH; Pech M; Wieners G; Spors B; Werk M; Rosner C; Lopez Hänninen E; Felix R
    Strahlenther Onkol; 2004 May; 180(5):274-80. PubMed ID: 15127157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound-assisted catheter placement in CT-guided HDR brachytherapy for the local ablation of abdominal malignancies: Initial experience.
    Damm R; El-Sanosy S; Omari J; Damm R; Hass P; Pech M; Powerski M
    Rofo; 2019 Jan; 191(1):48-53. PubMed ID: 30308690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial Experience with CT-Guided High-Dose-Rate Brachytherapy in the Multimodality Treatment of Neuroendocrine Tumor Liver Metastases.
    Schippers AC; Collettini F; Steffen IG; Wieners G; Denecke T; Pavel M; Wust P; Gebauer B
    J Vasc Interv Radiol; 2017 May; 28(5):672-682. PubMed ID: 27645463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous computed tomography-guided high-dose-rate brachytherapy ablation of breast cancer liver metastases: initial experience with 80 lesions.
    Collettini F; Golenia M; Schnapauff D; Poellinger A; Denecke T; Wust P; Riess H; Hamm B; Gebauer B
    J Vasc Interv Radiol; 2012 May; 23(5):618-26. PubMed ID: 22525020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications of Computed Tomography-Guided High-Dose-Rate Brachytherapy (CT-HDRBT) and Risk Factors: Results from More than 10 Years of Experience.
    Böning G; Büttner L; Jonczyk M; Lüdemann WM; Denecke T; Schnapauff D; Wieners G; Wust P; Gebauer B
    Cardiovasc Intervent Radiol; 2020 Feb; 43(2):284-294. PubMed ID: 31797103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Percutaneous treatment of hilar cholangiocarcinoma completed by high-dose rate brachytherapy. Experience in the first 5 cases].
    Righi D; Maass J; Zanon E; Tettoni S; Orecchia R; Lazzari R; Ragona R; Gandini G
    Radiol Med; 1994; 88(1-2):79-85. PubMed ID: 7520594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholangiocarcinoma: clinical significance of tumor location along the extrahepatic bile duct.
    Alden ME; Waterman FM; Topham AK; Barbot DJ; Shapiro MJ; Mohiuddin M
    Radiology; 1995 Nov; 197(2):511-6. PubMed ID: 7480704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study.
    Válek V; Kysela P; Kala Z; Kiss I; Tomásek J; Petera J
    Eur J Radiol; 2007 May; 62(2):175-9. PubMed ID: 17344008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel endoscopic approach to brachytherapy in the management of Hilar cholangiocarcinoma.
    Simmons DT; Baron TH; Petersen BT; Gostout CJ; Haddock MG; Gores GJ; Yeakel PD; Topazian MD; Levy MJ
    Am J Gastroenterol; 2006 Aug; 101(8):1792-6. PubMed ID: 16780552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.